Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, and Sodium-Glucose Cotransporter-2 Inhibitors and COVID-19 Outcomes

Purpose: It has been reported that dipeptidyl peptidase-4 inhibitors (DPP-4i), glucagon-like peptide-1 receptor agonists (GLP-1 RA), and sodium-glucose cotransporter-2 inhibitors (SGLT-2i) have a role in modulation of inflammation associated with coronavirus disease 2019 (COVID-19). This study asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Foresta, Andreana, Ojeda-Fernandez, Luisa, Macaluso, Giulia, Roncaglioni, Maria Carla, Tettamanti, Mauro, Fortino, Ida, Leoni, Olivia, Genovese, Stefano, Baviera, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974363/
https://www.ncbi.nlm.nih.gov/pubmed/36933975
http://dx.doi.org/10.1016/j.clinthera.2023.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974363/
https://www.ncbi.nlm.nih.gov/pubmed/36933975
http://dx.doi.org/10.1016/j.clinthera.2023.02.007

Ejemplares similares